Basal Cell Carcinoma
194
23
37
103
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
31 trials with published results (16%)
Research Maturity
103 completed trials (53% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.2%
10 terminated out of 194 trials
91.2%
+4.6% vs benchmark
8%
15 trials in Phase 3/4
30%
31 of 103 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 103 completed trials
Clinical Trials (194)
Inter-Operator Variability in the Clinical Staging and Therapeutic Management of Basal Cell Carcinoma
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
Study Evaluating the Interest of Vismodegib as Neo-adjuvant Treatment of Basal Cell Carcinoma (BCC)
Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies
A Study on Radiation Therapy Guided by the Reflectance Confocal Microscopy (RCM)/Optical Coherence Tomography (OCT) Device in People With Basal Cell Carcinoma
Dose Escalation Trial to Evaluate Dose Limiting Toxicity/Maximum Tolerated Dose of Microneedle Arrays Containing Doxorubicin (D-MNA) in Basal Cell Carcinoma (BCC)
Investigation of Mohs Surgical Margins Using Two Photon Microscopy
FLASH Radiotherapy for Skin Cancer
CivaDerm(TM) Surface Therapy Pilot Study
Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma
Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery
BCC-One-Stop-Study
Post-authorization Safety Study on the Long Term Safety of Sonidegib in Patients With Locally Advanced Cell Carcinoma
Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)
Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma
Pilot Study of Line-Field Confocal Optical Coherence Tomography for Detection of Mohs Micrographic Surgery Margins of Basal Cell Carcinomas
Clinical Trial to Evaluate BO-112 in Patients With Basal Cell Carcinoma (BCC)
Basal Cell Carcinoma Chemoprevention Trial
Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma